CYTOSINE-ARABINOSIDE THERAPY FOR HERPES ZOSTER IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:6
作者
VANDERSARL, JV
PANETTIERE, F
DAVIS, CM
FENTON, RM
机构
关键词
D O I
10.1097/00007611-197208000-00021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:995 / +
页数:1
相关论文
共 10 条
[1]   THE NATURAL HISTORY OF HERPES ZOSTER [J].
BURGOON, CF ;
BURGOON, JS ;
BALDRIDGE, GD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 164 (03) :265-269
[2]  
CALABRES.P, 1965, ANN NY ACAD SCI, V130, P192
[3]   STUDIES OF ENZYMATIC DEAMINATION OF CYTOSINE ARABINOSIDE .1. ENZYME DISTRIBUTION AND SPECIES SPECIFICITY [J].
CAMIENER, GW ;
SMITH, CG .
BIOCHEMICAL PHARMACOLOGY, 1965, 14 (10) :1405-&
[4]  
CHOW AWC, 1970, JAMA-J AM MED ASSOC, V214, P1635
[5]  
Hall T C, 1969, Trans Assoc Am Physicians, V82, P201
[6]   CYTOSINE ARABINOSIDE THERAPY FOR DISSEMINATED HERPES ZOSTER IN A PATIENT WITH IGG PYROGLOBULINEMIA [J].
MCKELVEY, EM ;
KWAAN, HC .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1969, 34 (05) :706-+
[7]   SPREAD OF ZOSTER VIRUS IN HUMAN EMBRYONIC LUNG CELLS + INHIBITORY EFFECT OF IODODEOXYURIDINE [J].
RAPP, F ;
VANDERSLICE, D .
VIROLOGY, 1964, 22 (03) :321-+
[8]  
SELIGMAN BR, 1970, LANCET, V1, P307
[9]  
TALLEY RW, 1967, CANCER-AM CANCER SOC, V20, P809, DOI 10.1002/1097-0142(1967)20:5<809::AID-CNCR2820200536>3.0.CO
[10]  
2-0